Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.28 USD | -6.65% | -9.61% | -16.02% |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
May. 24 | Recursion Pharmaceuticals, Inc. Announces Chair of the Board Changes | CI |
Financials (USD)
Sales 2024 * | 58.86M | Sales 2025 * | 63.02M | Capitalization | 1.97B |
---|---|---|---|---|---|
Net income 2024 * | -401M | Net income 2025 * | -472M | EV / Sales 2024 * | 27.4 x |
Net cash position 2024 * | 358M | Net cash position 2025 * | 336M | EV / Sales 2025 * | 25.9 x |
P/E ratio 2024 * |
-5.04
x | P/E ratio 2025 * |
-4.55
x | Employees | 500 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.87% |
1 day | -6.65% | ||
1 week | -9.61% | ||
1 month | +5.88% | ||
3 months | -38.48% | ||
6 months | +20.88% | ||
Current year | -16.02% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 41 | 13-11-04 | |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20-03-19 |
Chairman | 60 | 20-03-31 | |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.51% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.28 | -6.65% | 6,518,092 |
24-05-30 | 8.87 | +3.38% | 3,384,268 |
24-05-29 | 8.58 | -4.56% | 5,740,988 |
24-05-28 | 8.99 | -1.86% | 4,574,685 |
24-05-24 | 9.16 | +1.44% | 3,414,274 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.02% | 1.97B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- RXRX Stock